Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, H. W.
Right arrow Articles by Alderman, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, H. W.
Right arrow Articles by Alderman, M. H.
Related Collections
Right arrow Depression
Right arrow Blood Pressure
Right arrow Coronary Artery Disease
Psychosomatic Medicine 63:203-209 (2001)
© 2001 American Psychosomatic Society


SPECIAL ISSUE: COMORBIDITY STUDIES

History of Treatment for Depression: Risk Factor for Myocardial Infarction in Hypertensive Patients

Hillel W. Cohen, DrPH, Shantha Madhavan, DrPH and Michael H. Alderman, MD

From the Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, New York.

Address reprint requests to: Hillel W. Cohen, DrPH, Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Room 1302 Belfer, 1300 Morris Park Ave., Bronx, NY 10461. Email: hicohen{at}aecom.yu.edu

OBJECTIVE: Psychological factors have been suspected of contributing to the development of cardiovascular disease. This study examined the relationship between a self-reported history of treatment for depression and subsequent myocardial infarction among treated hypertensive patients.

METHODS: Participants (5564) in a union-sponsored, hypertension control program in New York City, who entered the program during 1981–1994 without a history of cardiovascular disease and who were asked whether they had been treated for depression, were followed in a prospective cohort study. The primary outcome of interest was hospitalization or death due to myocardial infarction.

RESULTS: At entry, 3.5% of men and 6.4% of women reported a history of treatment for depression. During 4.9 years (average) of follow-up, 112 fatal and nonfatal myocardial infarctions were recorded. The sex-adjusted relative risk of myocardial infarction was 2.24 (confidence interval = 1.13–4.45). Controlling for known cardiovascular risk factors with multivariate proportional hazards models, history of treatment for depression was significantly associated with subsequent myocardial infarction (hazard ratio = 2.10, confidence interval = 1.04–4.23).

CONCLUSIONS: A self-reported history of treatment for depression is independently associated with subsequent myocardial infarction in treated hypertensive patients without prior cardiovascular disease. Whether additional or different treatment for depression will be cardioprotective is unknown and merits further study.

Key Words: depression • myocardial infarction • hypertension.

Abbreviations: CI = confidence interval; CVD = cardiovascular disease; DSM = Diagnostic and Statistical Manual of Mental Disorders; MI = myocardial infarction; RR = relative risk.




This article has been cited by other articles:


Home page
Eval Health ProfHome page
J. Peters and K. Mengersen
Selective Reporting of Adjusted Estimates in Observational Epidemiology Studies: Reasons and Implications for Meta-analyses
Eval Health Prof, December 1, 2008; 31(4): 370 - 389.
[Abstract] [PDF]


Home page
Eur Heart JHome page
A. Nicholson, H. Kuper, and H. Hemingway
Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies
Eur. Heart J., December 1, 2006; 27(23): 2763 - 2774.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
J. M. Martinez, L. B. Marangell, N. M. Simon, S. Miyahara, S. R. Wisniewski, J. Harrington, M. H. Pollack, G. S. Sachs, and M. E. Thase
Baseline Predictors of Serious Adverse Events at One Year Among Patients With Bipolar Disorder in STEP-BD
Psychiatr Serv, December 1, 2005; 56(12): 1541 - 1548.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
L. D. Ried, M. J. Tueth, E. Handberg, S. Kupfer, C. J. Pepine, and the INVEST Study Group
A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in Patients Treated With a Calcium Antagonist Versus an Atenolol Hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST)
Psychosom Med, May 1, 2005; 67(3): 398 - 406.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
L J Tata, J West, C Smith, P Farrington, T Card, L Smeeth, and R Hubbard
General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction
Heart, April 1, 2005; 91(4): 465 - 471.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
E. J. Giltay, J. M. Geleijnse, F. G. Zitman, T. Hoekstra, and E. G. Schouten
Dispositional Optimism and All-Cause and Cardiovascular Mortality in a Prospective Cohort of Elderly Dutch Men and Women
Arch Gen Psychiatry, November 1, 2004; 61(11): 1126 - 1135.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. W. Cohen, S. M. Hailpern, and M. H. Alderman
Glucose-Cholesterol Interaction Magnifies Coronary Heart Disease Risk for Hypertensive Patients
Hypertension, May 1, 2004; 43(5): 983 - 987.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
R. D. Jindal, D. J. Buysse, and M. E. Thase
Maintenance Treatment of Insomnia: What Can We Learn From the Depression Literature?
Am J Psychiatry, January 1, 2004; 161(1): 19 - 24.
[Abstract] [Full Text]


Home page
StrokeHome page
D. Jakovljevic and J. Tuomilehto
Use of Selective Serotonin Reuptake Inhibitors and the Risk of Stroke: Is There Reason for Concern?
Stroke, June 1, 2002; 33(6): 1448 - 1449.
[Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. E. Dimsdale
Comorbidity Studies: A Core Area for Psychosomatic Research
Psychosom Med, March 1, 2001; 63(2): 201 - 202.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Psychosomatic Society